hema.to GmbH Alternatives & Competitors
12 companies similar to hema.to GmbH — AI cytometry to advance precision immune medicine
Companies similar to hema.to GmbH
CliniNote - unlocking clinical data
Unlocking power of clinical data.
Poland
Novigenix SA
Leader in Immuno-Transcriptomic Precision Medicine solutions
Lausanne, Switzerland
Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advanc...
Chicago, United States
Sight Diagnostics
Morphology-Based Digital Blood Diagnostics
Israel
Rival Readout
Competing with hema.to GmbH? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
MVision AI
MVision AI is a pioneering software service provider for precision radiotherapy treatment...
Helsinki, Finland
Qritive
Qritive makes cancer diagnostics fast, accurate, and affordable
Singapore, Singapore
LungLife AI
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...
Thousand Oaks, United Sta...
Vara
Making data-driven breast cancer screening accessible to everyone; deeptech with a measura...
Berlin, Germany
Craif Inc.
Harnessing the power of urinary miRNA to detect cancer early
Irvine, United States
Aevus Precision Rx
Machine-Learning powered prescription guidance for Type 2 Diabetes
Norman, United States
IPMD, Inc.
Creating a Better World with Innovative Emotional AI
San Mateo, United States
MetaGenomika
A knowledge-based company focused on developing AI-powered Molecular Diagnostics for chron...
Seattle, United States
About hema.to GmbH
hema.to GmbH, founded in 2021, is a deeptech AI company based in Germany with a mission exemplified by their slogan, "AI cytometry to advance precision immune medicine." The company focuses on innovating within the healthcare sector by leveraging artificial intelligence to enhance cytometry, ultimately aiming to tailor...
AI-driven cytometry solutions, Workflow automation, Diagnostic support for B-NHL, Real-time collaborative tools, Cloud-based workflow platforms
Hematology labs, Clinical diagnostics labs, Medical professionals in hematopathology, Research laboratories, Laboratories focusing on B-NHL
Deeptech, AI-powered Cytometry, Precision Immune Medicine, Automated Blood Cancer Detection, Flow Cytometry, Healthcare Innovation, Immune System Analysis, Personalized Medicine, Digital Health, Medical Diagnostics, Cancer Treatment Optimization
B2B, SaaS
Subscription, Usage Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around hema.to GmbH: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at hema.to GmbH on 28 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
